In addition, a study indicated that Mylabris exerted a therapeutic effect on leukemia by triggering DNA damage, inducing apoptosis, as well as inhibiting the growth and proliferation of tumor cells through regulation of tumor protein 53 (TP53) and phosphatase and tensin homolog and p53 signaling pathway based on bioinformatics and systematic pharmacology [40]. Here, TP53 is linked to leukemia.